These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32502586)

  • 1. Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.
    Stewart CR; Algu L; Kamran R; Leveille CF; Abid K; Rae C; Lipner SR
    J Am Acad Dermatol; 2021 Nov; 85(5):1227-1239. PubMed ID: 32502586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure.
    Gupta AK; Daigle D; Paquet M
    J Am Podiatr Med Assoc; 2015 Jul; 105(4):357-66. PubMed ID: 25032982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis: Rapid Evidence Review.
    Frazier WT; Santiago-Delgado ZM; Stupka KC
    Am Fam Physician; 2021 Oct; 104(4):359-367. PubMed ID: 34652111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal therapy for onychomycosis in children.
    Feldstein S; Totri C; Friedlander SF
    Clin Dermatol; 2015; 33(3):333-9. PubMed ID: 25889135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of onychomycosis].
    Reisberger EM; Szeimies RM
    Med Klin (Munich); 2000 Nov; 95(11):618-28. PubMed ID: 11143542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal Drug Use for Onychomycosis.
    Thomas J; Peterson GM; Christenson JK; Kosari S; Baby KE
    Am J Ther; 2019; 26(3):e388-e396. PubMed ID: 31082864
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.
    Gupta AK; Foley KA; Mays RR; Shear NH; Piguet V
    Br J Dermatol; 2020 Feb; 182(2):287-299. PubMed ID: 31120134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
    Endringer Pinto F; Bagger C; Kunze G; Joly-Tonetti N; Thénot JP; Osman-Ponchet H; Janfelt C
    Mycoses; 2020 Aug; 63(8):869-875. PubMed ID: 32406142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.